positron issued from the β + emitters induced in the patient tissues along the beam path. These methods require being able to detect with a huge efficiency, and with a minimum dead time, these secondary particles emitted when the beam hits the patient. The LAPD is similar to a conventional Positron Emission Tomography camera. The 511 keV γ are detected and the reconstructed line of responses allow to measure the β + activity distribution. Nevertheless, when trying to use γ from positron annihilations for the ballistic control in hadrontherapy, the large γ prompt background should be taken into account and properly rejected. This detector is made of two half-rings of 120 channels each (figure 1). Figure 4 : the LAPD, a PET-like detector dedicated to beam ballistic control in hadrontherapy.
Each channel consists of a 13*13*15 mm 3 LYSO crystal glued to a PMT. The PMT signal is sent to an Analog Sampling Module (ASM board). This VME 6U board is based on the DRS4 chip technology (Switch Capacitor Array) from the Paul Sherrer Institute and was specially designed for the LAPD detector. This board receives up to 24 differential analog input signals, with maximum amplitude of 600 mV, digitized by 12 bits -33 MHz ADC. The sampling rate varies between 1 and 5 GHz, for a maximum buffer size of 1024 samples. The first part of the talk is devoted to the description of the detector and its electronics. Then, we describe the various trigger strategy, and the on-going upgrade of the VME-based acquisition system to a µTCA-based technology. The selection of the coincident 511 keV γ is also discussed, and the reconstruction using an iterative MLEM algorithm is presented. In the last part of the talk, few results from an experiment with one third of the detector, using proton and carbon ion beams at the Heidelberg Ion-Beam Therapy Center in 2014, are also described, and the Coincidence Resolution Time and energy resolution are given. First reconstruction results, obtained with a phantom filled with a high intensity FDG source at the cancer research center of Clermont-Ferrand in 2015 are also shown. This detector is now characterized, and will be installed at the Lacassagne hadrontherapy center (Nice, France), on the 65 MeV line (Medicyc) in December 2015 first, and on the future 230 MeV line (S2C2 from IBA) in 2016. The capability of this detector and its associated electronics to measure the ballistic of the proton beam in real clinical conditions with a sufficient precision will be evaluated.
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References: [1] Purpose: Ion beams are used for highly precise radiotherapy, making an accurate dose deposition in tissue crucial. However, this accuracy can be compromised by unpredictable changes of the patient. Therefore an online monitoring of the beam within the patient is of large interest. The main challenge is given by stopping of the entire beam inside of the patient. Our group investigates the possibility to collect and reconstruct the information about the beam extension in the patient by detecting light ions emitted from the irradiated object, suggested in [1] . Exploiting the directions of secondary ions measured, a method for visualization and quantification of the carbon ion beam profile in a homogeneous phantom was published in [2] . In this contribution, the capability of the method to detect inhomogeneities in otherwise homogeneous phantoms is presented. Materials & methods: The experiments were performed at the Heidelberg Ion Beam Therapy Center (HIT) in Germany. Narrow carbon ion beams of therapy-relevant energies, were directed onto homogneneous plastic phantoms with a typical head size. Secondary ions emerging from the phantom during the irradiation, were detected by a Timepix detector [3] developed by the Medipix Collaboration at CERN. A multilayered detector, consisting of 3 parallel Timepix detectors, was used to measure their tracks in 3D. The track distributions acquired with a full phantom were compared with cases when parts of the phantom were missing at several positions, simulating cavities in the body. Results: It was found that exploiting the information carried by secondary ions enables to visualize cavities in the irradiated volume at different positions of the Bragg curve. The method was found to be sensitive also to cavities situated behind the Bragg peak (in the fragment tail). Moreover, a three-dimensional image reconstruction based on maximum likelihood expectation maximization (MLEM) exploiting the measured secondary particle tracks was developed. In the resulting images, air cavities and inhomogeneities with density differences down to 0.3 g cm −3 to the surrounding material are clearly visualized for the first time. Conclusions: Our experimental results demonstrate that this novel imaging modality enables clear visualization of down to 1 cm-sized air cavities in head-sized phantoms, under clinical irradiation conditions. Therefore we conclude that secondary ions, being a by-product of the irradiation, are an attractive source of information on the actual beam extension in the irradiated body. Keywords: carbon ion radiotherpy, in-vivo beam monitoring, secondary charged particles Purpose: To evaluate the significance of fractionated administration of thalidomide combined with γ-ray irradiation in terms of local tumor response and lung metastatic potential, referring to the response of intratumor quiescent (Q) cells. Materials/methods: B16-BL6 melanoma tumor-bearing C57BL/6 mice were continuously given 5-bromo-2'deoxyuridine (BrdU) to label all proliferating (P) cells. The tumor-bearing mice then received γ-ray irradiation after thalidomide treatment through a single or 2 consecutive daily intraperitoneal administrations up to a total dose of 400 mg/kg in combination with an acute hypoxia-releasing agent (nicotinamide, 1,000 mg/kg, intraperitoneally administered) or mild temperature hyperthermia (MTH, 40 centigrade for 60 minutes). Immediately after the irradiation, cells from some tumors were isolated and incubated with a cytokinesis blocker. The responses of the Q and total (= P + Q) cell populations were assessed based on the frequency of micronuclei using immunofluorescence staining for BrdU. In other tumor-bearing mice, 17 days after irradiation, macroscopic lung metastases were enumerated. Results: Thalidomide raised the sensitivity of the total cell population more remarkably than Q cells in both single and daily administrations. Daily administration of thalidomide elevated the sensitivity of both the total and Q cell populations, but especially the total cell population, compared with single administration. Daily administration, especially combined with MTH, decreased the number of lung metastases. Conclusions: Daily fractionated administration of thalidomide in combination with γ-ray irradiation was thought to be more promising than single administration because of its potential to enhance local tumor response and repress lung metastatic potential. Purpose: The Malthus model is an evidence based simulation of radiotherapy demand in England, which was designed to estimate radiotherapy utilisation at local and national level, in order to assist in planning of radiotherapy services. The model utilised cancer registration data from the national cancer registration service, together with predictions of population growth from the Office of National Statistics, and cancer incidence projections. We present the results of an updated model that utilises the latest population projection estimates, and cancer incidence data. Materials and Methods: Base data on cancer registration was provided by the National Cancer Intelligence Network, broken down by disease site, local Clinical Commissioning Groups (CCGs), age and sex. Equivalent population data was sourced from the Office for National Statistics. These two datasets were combined with data from 2,000 evidencebased clinical decisions, covering 22 different cancer sites. Clinical practice was peer-reviewed by over 100 British oncologists and at a national forum. An updated cancer incidence projection model and population projection model were also used to enable annual demand predictions up to 2035. Results: The Malthus model estimates that the access rate for radiotherapy in England in 2015 should be 40.5% with a fraction burden of approximately 47,500 fractions per million population. To highlight how different regions within a country can be, Table 1 displays two regions and the England average for comparison. The predicted demand for radiotherapy is also increasing for England. Over the next few year the predicted fractions per million will increase by 0.9% per year, this will increase to 1% per year in 2020 and is expected to hit 1.1% per year by 2026.
Keywords
Conclusions: The Malthus model with updated cancer incidence data suggests a radiotherapy utilisation rate of 40.5%, with a predicted annual increase of fractions per million of around 1% per year. Whilst the observed rates of radiotherapy utilisation still lag behind the model's predictions, the observed activity increases in England (from the Radiotherapy Data Set) over the last 3 years exceed the rate of rise in predicted demand. Customised 1a,b )has been modified for purpose of MR imaging during dynamic detector-tracking (i.e. so named 'MR guided dynamic dosimaging'). The detector was tested for MRI-safety and functionality without irradiation in a 1T fringe field of 3T Siemens Skyra MRI. As solid water can not be visualized on MRI a tissue-equivalent, gel-water phantom (CIRS® Computerized Imaging Reference Systems Inc. VA, USA), providing signal for detector and fiducial visualisation, was utilised to enable MR imaging (fast spin echo sequence). Results: MR images of a non-powered detector system demonstrated detector visualization (see figure 1c ). Detector movements approximating breathing were also acquired during dynamic MRI acquisition (fast gradient echo), showing that fiducial markers could be visualised when placed on a passive device and tracked. The detector functioned at the 1T bore entry position to simulate the magnetic field of our impending MR linac whilst a water phantom was imaged simultaneously at the mid-bore 3T position, with noise (see figure 1d ) seen due to detector RF interference being reduced by aluminium foil shielding of the device and cables (figure 1e). Conclusions: The current MRI-guided dynamic dosimaging setup has been demonstrated to be successful in detector visualisation and tracking with a non-powered detector. Noise reduction has been achieved with the detector in operational mode. A MRI-compatible motion platform will be paired with M512. These measurements will be compared to acquisition in MRI-linac magnetic fields on the MRI-linac device being installed at the Ingham Institute in Australia. 

